Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare Inks Deal to Offer AccuRef Reference Materials

NEW YORK (GenomeWeb) — SeraCare Life Sciences announced today that it has signed an agreement under which it will offer AccuRef Diagnostics' line of CRISPR-engineered cell line reference materials.

Under the terms of the deal, Milford, Massachusetts-based SeraCare will market and sell AccuRef's portfolio of CRISPR-engineered cell line-based cancer reference materials beginning in January in all markets except for China. The deal includes products geared for low-to-mid plex clinical genomic applications such as qPCR, digital PCR, Sanger sequencing, mass spec, and small targeted next-generation sequencing gene panels.

Additional terms were not disclosed.

AccuRef — a Milpitas, California-based division of global molecular and cellular reference standards provider Applied StemCell — was established last year.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.